Hidetomo Kitamura
16Patents
7h-index
31Co-inventors
66Inventor score
Filing activity: Mar 6, 1998 → Dec 13, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7320792B2 | Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist | Human Necessities | 117 | Expired |
| US7642243B2 | Method of treating arthritis and promoting growth of articular chondrocytes | Human Necessities | 30 | Expired |
| US6500854B1 | Chondrongenesis promotors and indolin-2-one derivatives | Chemistry; Metallurgy | 17 | Expired |
| US8562990B2 | Method of treating psoriatic arthritis with an IL-6 receptor antibody | Human Necessities | 16 | Active |
| US8597644B2 | Method for treating psoriasis by administering an antibody to interleukin-6 receptor | Human Necessities | 16 | Active |
| US8431127B2 | Method for treating pruritus comprising administering an NR10 antagonist | Chemistry; Metallurgy | 9 | Active |
| US9028821B2 | Method of treating an inflammatory disease comprising administering an NR 10 antibody antagonist | Chemistry; Metallurgy | 7 | Active |
| US8658373B2 | Method of screening for an agent for treating arthritis and promoting growth of articular chondrocytes | Human Necessities | 6 | Active |
| US9745378B2 | Antibodies that bind to cytokine receptor NR10 | Chemistry; Metallurgy | 6 | Active |
| US10544227B2 | Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredient | Chemistry; Metallurgy | 4 | Active |
| US11773173B2 | Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredient | Chemistry; Metallurgy | 1 | Active |
| US6716628B2 | Chondrogenesis promoters and indolin-2-one derivatives | Chemistry; Metallurgy | 1 | Expired |
| US12077577B2 | Polypeptide comprising aggrecan binding domain and carrying moiety | Chemistry; Metallurgy | 1 | Active |
| US7037717B1 | Cell line and screening method with the use of the same | Chemistry; Metallurgy | 0 | Expired |
| US8815803B2 | Method for increasing body height comprising systemic administration of CNP-53 | Physics | 0 | Active |
| US9993462B2 | Hydantoin derivative-containing pharmaceutical composition | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.